Ugo Giovanni Falagario
Università degli Studi di Foggia
H-index: 22
Europe-Italy
Top articles of Ugo Giovanni Falagario
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy
Prostate Cancer and Prostatic Diseases
2024/1/5
Prediagnostic Prostate-specific Antigen Testing and Clinical Characteristics in Men with Lethal Prostate Cancer
European Urology Open Science
2024/4/1
Lars Björnebo
H-Index: 2
Ugo Giovanni Falagario
H-Index: 8
Henrik Grönberg
H-Index: 51
Tobias Nordström
H-Index: 17
Anna Lantz
H-Index: 11
MP74-12 IMPACT OF MAGNETIC RESONANCE IMAGING SCAN AND IMAGE ACQUISITION PROTOCOL IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER AT BIOPSY: RESULTS FROM THE PROMOD WORKING …
The Journal of Urology
2024/5
Prognostic Value of P63 Expression in Muscle-Invasive Bladder Cancer and Association with Molecular Subtypes—Preliminary Report
Current Issues in Molecular Biology
2024/3/14
Ugo Giovanni Falagario
H-Index: 8
MP14-02 IDENTIFY THE OPTIMAL CANDIDATES FOR ADJUVANT ANDROGEN DEPRIVATION THERAPY AMONG PATIENTS WITH DETECTABLE PSA AFTER RADICAL PROSTATECTOMY
The Journal of Urology
2024/5
The Impact of Venous Thromboembolism on Upper Tract Urothelial Carcinomas Undergoing Open or Minimally Invasive Radical Nephroureterectomy in the USA: Perioperative Outcomes …
European Urology Focus
2024/3/2
PD29-12 THE IMPACT OF THE TIME ELAPSED BETWEEN PRIMARY TREATMENT AND BCR ON CANCER SPECIFIC MORTALITY IN PATIENTS WHO EXPERIENCED BCR AFTER PRIMARY TREATMENT
The Journal of Urology
2024/5
PD45-06 ACCURACY OF THE MRI 5-POINT LIKERT SCORE TO PREDICT EXTRA-PROSTATIC EXTENSION AND SEMINAL VESICLE INVASION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE …
The Journal of Urology
2024/5
MP19-10 ADDITIONAL VALUE OF MRI IN PATIENTS WITH PSA> 10 NG/ML AND/OR POSITIVE DRE: IS MRI ALWAYS NEEDED?
The Journal of Urology
2024/5
The impact of the time elapsed between primary treatment and BCR on cancer specific mortality in patients who experienced BCR after primary treatment
European Urology
2024/3/1
PD19-08 EAU RISK STRATIFICATION FOR PROSTATE CANCER ACCORDING TO SYSTEMATIC BIOPSY, TARGET BIOPSY AND COMBINED BIOPSY RESULTS AND FINAL PATHOLOGY CONCORDANCE. RESULTS FROM THE …
The Journal of Urology
2024/5
Ugo Giovanni Falagario
H-Index: 8
Emanuele Montanari
H-Index: 22
Pierluigi Bove
H-Index: 19
Alessandro Sciarra
H-Index: 6
PD46-05 PENILE LENGTH AFTER INFLATABLE PENILE PROSTHESIS IMPLANT: DOES IT REALLY MATTER?
The Journal of Urology
2024/5
PD57-12 PSA RESPONSE AFTER RADIOTHERAPY. IS THERE A DEFINITION OF PSA PERSISTENCE AFTER RT?
The Journal of Urology
2024/5
Minimally invasive surgical therapies (MISTs) for lower urinary tract symptoms (LUTS): promise or panacea?
2024/3/1
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care
Prostate Cancer and Prostatic Diseases
2024/2/12
MP47-03 IMPACT OF LOW-INTENSITY EXTRACORPOREAL SHOCKWAVE THERAPY ON VASCULAR PARAMETERS AND SEXUAL FUNCTION IN PATIENTS WITH ARTERIOGENIC ERECTILE DYSFUNCTION
The Journal of Urology
2024/5
Mini and Standard Percutaneous Nephrolithotomy in Obese Patients. Results from a Single-surgeon Large Series
European Urology Open Science
2024/5/1
Ugo Giovanni Falagario
H-Index: 8
Antioxidant treatment for oligoasthenoteratozoospermia and varicocele: a DBPC trial to evaluate the impact of age and body mass index
Asian Journal of Andrology
2024/2/2
Integrating the PD-L1 Prognostic Biomarker in Non-Muscle Invasive Bladder Cancer in Clinical Practice—A Comprehensive Review on State-of-the-Art Advances and Critical Issues
2024/4/10
Ugo Giovanni Falagario
H-Index: 8
Re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. Prostate-specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of …
European Urology Oncology
2024/2/1
Ugo Giovanni Falagario
H-Index: 8
Alberto Martini
H-Index: 13
Francesco Pellegrino
H-Index: 2
Anna Lantz
H-Index: 11
Co-Authors
